Whitening effect of novel peptide mixture by regulating melanosome biogenesis, transfer and degradation

다국어 초록 (Multilingual Abstract)

Peptides are short chain of amino acids linked by peptide bonds. They are widely used as effective and biocompatible active ingredients in cosmetic industry. In this study, we developed novel peptide mixture and identified its anti-pigmentation effect on melanocytes and keratinocytes. Our results revealed that peptide mixture inhibited melanosome biogenesis through the regulation of microphthalmia-associated transcription factor, a key factor of melanogenesis in melanocytes. And we observed that peptide mixture inhibited melanosome uptake through the reduction of protease-activated receptor 2, a phagocytosis-related receptor in keratinocytes. Furthermore, peptide mixture activated autophagy system resulting in degradation of transferred melanosomes in keratinocytes. The anti-pigmentation effect of multi-targeting peptide mixture was assessed in a human skin equivalent model (MelanoDerm). Melanin contents in epidermal layer were significantly decreased by topical treatment of peptide mixture, suggesting that it can be applied as a novel cosmetics material having a whitening function.

목차 (Table of Contents)

• INTRODUCTION METHODS RESULTS DISCUSSION ACKNOWLEDGEMENTS REFERENCES

참고문헌 (Reference)

1 Chakraborty A, "Ultraviolet B and melanocyte-stimulating hormone(MSH)stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes" 105 : 655-659, 1995

2 Kalluri H, "Transdermal delivery of proteins" 12 : 431-441, 2011

3 Pai VV, "Topical peptides as cosmeceuticals" 83 : 9-18, 2017

4 Schagen SK, "Topical peptide treatments with effective anti-aging results" 4 : 16-, 2017

5 Li L, "The signaling involved in autophagy machinery in keratinocytes and therapeutic approaches for skin diseases" 7 : 50682-50697, 2016

6 Juhasz MLW, "The role of systemic treatments for skin lightening" 17 : 1144-1157, 2018

7 Seiberg M, "The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions" 254 : 25-32, 2000

8 Hachiya A, "The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation" 116 : 578-586, 2001

9 Kameyama K, "The expression of tyrosinase, tyrosinaserelated proteins 1 and 2(TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities" 8 : 97-104, 1995

10 Speeckaert R, "The biology of hyperpigmentation syndromes" 27 : 512-524, 2014

11 Kim YM, "The activation of melanogenesis by pCREB and MITF signaling with extremely low-frequency electromagnetic fields on B16F10 melanoma" 162 : 25-32, 2016

12 Kuroda TS, "The actin-binding domain of Slac2-a/melanophilin is required for melanosome distribution in melanocytes" 23 : 5245-5255, 2003

13 Pillaiyar T, "Skin whitening agents : medicinal chemistry perspective of tyrosinase inhibitors" 32 : 403-425, 2017

14 Ohbayashi N, "Role of Rab family GTPases and their effectors in melanosomal logistics" 151 : 343-351, 2012

15 Schauer E, "Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes" 93 : 2258-2262, 1994

16 Chakraborty AK, "Production and release of proopiomelanocortin(POMC)derived peptides by human melanocytes and keratinocytes in culture : regulation by ultraviolet B" 1313 : 130-138, 1996

17 Epstein JH, "Photocarcinogenesis, skin cancer, and aging" 9 : 487-502, 1983

18 Oberhofer A, "Myosin Va's adaptor protein melanophilin enforces track selection on the microtubule and actin networks in vitro" 114 : E4714-E4723, 2017

19 Chiaverini C, "Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport" 283 : 12635-12642, 2008

20 Provance DW, "Melanophilin, the product of the leaden locus, is required for targeting of myosin-Va to melanosomes" 3 : 124-132, 2002

21 Strom M, "Melanophilin links Rab27a and myosin Va function in melanosome transport" 277 : 25423-25430, 2002

22 Chang H, "Manassantin B inhibits melanosome transport in melanocytes by disrupting the melanophilin-myosin Va interaction" 25 : 765-772, 2012

23 Alves CP, "MYO5A gene is a target of MITF in melanocytes" 137 : 985-989, 2017

24 Hartman ML, "MITF in melanoma : mechanisms behind its expression and activity" 72 : 1249-1260, 2015

25 Van Gele M, "Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes" 128 : 2474-2484, 2008

26 Hirobe T, "Keratinocytes regulate the function of melanocytes" 32 : 200-204, 2014

27 Cardinali G, "Keratinocyte growth factor promotes melanosome transfer to keratinocytes" 125 : 1190-1199, 2005

28 Park JI, "Inhibitory effect of 2-methyl-naphtho[1, 2, 3-de]quinolin-8-one on melanosome transport and skin pigmentation" 6 : 29189-, 2016

29 Wu XS, "Identification of an organelle receptor for myosin-Va" 4 : 271-278, 2002

30 김보라, "Hesperidin Suppresses Melanosome Transport by Blocking the Interaction of Rab27A-Melanophilin" 한국응용약물학회 21 (21): 343-348, 2013

31 Makino-Okamura C, "Heparin inhibits melanosome uptake and inflammatory response coupled with phagocytosis through blocking PI3k/Akt and MEK/ERK signaling pathways in human epidermal keratinocytes" 27 : 1063-1074, 2014

32 Khaled M, "Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis" 277 : 33690-33697, 2002

33 Strömstedt AA, "Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL37" 53 : 593-602, 2009

34 Hirobe T, "Effects of fibroblast-derived factors on the proliferation and differentiation of human melanocytes in culture" 71 : 45-57, 2013

35 Yu JS, "Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells" 17 (17): S45-, 2010

36 Lajis AFB, "Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation : evidence from in vitro study" 18 : 703-727, 2019

37 Marepally S, "Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery" 8 : e82581-, 2013

38 Zhang L, "Cosmeceuticals and peptides" 27 : 485-494, 2009

39 Maymone MBC, "Correlating the Dermatology Life Quality Index and Skin Discoloration Impact Evaluation Questionnaire tools in disorders of hyperpigmentation" 45 : 361-362, 2018

40 Wakamatsu K, "Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor" 10 : 288-297, 1997

41 Reddy BY, "Bioactive oligopeptides in dermatology : part II" 21 : 569-575, 2012

42 Reddy B, "Bioactive oligopeptides in dermatology : part I" 21 : 563-568, 2012

43 Kim ES, "Autophagy mediates antimelanogenic activity of 3'-ODI in B16F1 melanoma cells" 442 : 165-170, 2013

44 Murase D, "Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes" 133 : 2416-2424, 2013

45 Imokawa G, "Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders" 17 : 96-110, 2004

46 Garcia-Jimenez A, "Action of tyrosinase on alpha and betaarbutin: a kinetic study" 12 : e0177330-, 2017

47 Lee CS, "A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKACREB-activated microphthalmia-associated transcription factor and tyrosinase expression" 22 : 762-764, 2013

48 Huang HC, "-Shogaol inhibits -MSH-induced melanogenesis through the acceleration of ERK and PI3K/Akt-mediated MITF degradation" 2014 : 842569-, 2014